2021 annual financial data

Arrowhead Pharmaceuticals 2021 Operating margin

Arrowhead Pharmaceuticals 2021 operating margin with verified reported values.

Direct answer

Operating margin was -107.77%.

Operating income was -149,036,000 USD and net income was -140,848,000 USD.
Operating cash flow was 171,312,000 USD.

Verified data

Revenue
138,287,000 USD
Operating income
-149,036,000 USD
Net income
-140,848,000 USD
Operating cash flow
171,312,000 USD